InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,967.23
(
-0.88%
)
US TECH 100
16,556.80
(
-2.24%
)
Dow Jones
37,986.40
(
0.56%
)
Brent Oil
86.63
(
0.00%
)
Bitcoin
64,049.85
(
0.35%
)
Post# of 3268
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

charhorse

Send PM Follow Ignore
Followers 7
Posts 1572
Boards Moderated 0
Alias Born 10/01/2006

charhorse

Re: None

Saturday, 03/01/2014 9:04:32 PM

Saturday, March 01, 2014 9:04:32 PM

Post# of 3268
Whats to become of the Bayer partnership?

The current due to expire in March 2014

MaterialScience below expectations

Bayer continues successful course in anniversary year
Dynamic development in the Life Science businesses, MaterialScience below expectations / Outstanding growth for recently launched pharmaceutical products - estimate of combined peak annual sales potential for the five products increased to at least EUR 7.5 billion / Group sales EUR 40,157 million (plus 1.0 percent; Fx & portfolio adj.: plus 5.1 percent) / EBIT advanced by 25.6 percent to EUR 4,934 million / EBITDA before special items up by 1.5 percent to EUR 8,401 million / Net income increased 32.7 percent to EUR 3,189 million / Core earnings per share up 5.8 percent to EUR 5.61 / Forecast for 2014: further growth in sales and earnings


see more Gifs

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up